本页面由Tiger Trade Technology Pte. Ltd.提供服务

Alterity Therapeutics Limited

3.34
-0.0845-2.47%
成交量:1.45万
成交额:4.85万
市值:6,045.82万
市盈率:-4.47
高:3.40
开:3.39
低:3.33
收:3.42
52周最高:7.00
52周最低:2.04
股本:1,812.57万
流通股本:1,245.82万
量比:1.61
换手率:0.12%
股息:- -
股息率:- -
每股收益(TTM):-0.7470
每股收益(LYR):-0.7470
净资产收益率:-43.23%
总资产收益率:-28.09%
市净率:2.14
市盈率(LYR):-4.47

数据加载中...

2020/03/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]